Matisse Capital Wave Life Sciences Ltd. Transaction History

Matisse Capital

$205 Million
Q3 2024

A detailed history of Matisse Capital transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Matisse Capital holds 13,463 shares of WVE stock, worth $191,982. This represents 0.05% of its overall portfolio holdings.

Number of Shares

13,463

Previous 14,063 4.27%

Holding current value

$191,982

Previous $70,000 57.14%

% of portfolio

0.05%

Previous 0.03%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	SELL	$5.12 - $9.01 $3,072 - $5,406	-600 Reduced 4.27%	13,463 $110,000
Q2 2024 Jul 30, 2024	BUY	$4.38 - $6.48 $657 - $972	150 Added 1.08%	14,063 $70,000
Q1 2024 Apr 30, 2024	BUY	$3.54 - $6.84 $6,726 - $12,996	1,900 Added 15.82%	13,913 $85,000
Q1 2023 Apr 27, 2023	SELL	$3.58 - $6.3 $716 - $1,260	-200 Reduced 1.64%	12,013 $52,000
Q4 2022 Jan 20, 2023	BUY	$3.18 - $7.0 $38,837 - $85,491	12,213 New	12,213 $85,000
Q1 2022 Apr 12, 2022	SELL	$2.0 - $3.28 $26,446 - $43,371	-13,223 Closed	0 $0
Q3 2021 Nov 08, 2021	SELL	$4.89 - $7.12 $9,535 - $13,884	-1,950 Reduced 12.85%	13,223 $65,000
Q2 2021 Aug 11, 2021	SELL	$5.65 - $7.47 $11,300 - $14,940	-2,000 Reduced 11.65%	15,173 $101,000
Q1 2021 May 14, 2021	BUY	$5.61 - $12.01 $11,079 - $23,719	1,975 Added 13.0%	17,173 $96,000
Q4 2020 Feb 12, 2021	SELL	$6.99 - $9.26 $219,388 - $290,634	-31,386 Reduced 67.38%	15,198 $119,000
Q3 2020 Nov 04, 2020	BUY	$8.49 - $19.54 $21,309 - $49,045	2,510 Added 5.69%	46,584 $395,000
Q2 2020 Jul 28, 2020	SELL	$7.44 - $11.29 $200,262 - $303,892	-26,917 Reduced 37.92%	44,074 $459,000
Q1 2020 May 07, 2020	BUY	$6.94 - $14.22 $15,823 - $32,421	2,280 Added 3.32%	70,991 $665,000
Q4 2019 Feb 12, 2020	BUY	$7.99 - $37.6 $17,777 - $83,660	2,225 Added 3.35%	68,711 $551,000
Q3 2019 Oct 28, 2019	BUY	$19.17 - $27.4 $108,502 - $155,084	5,660 Added 9.31%	66,486 $1.37 Million
Q2 2019 Aug 13, 2019	BUY	$22.93 - $42.84 $360,344 - $673,230	15,715 Added 34.84%	60,826 $1.59 Million
Q1 2019 Apr 24, 2019	BUY	$32.69 - $47.91 $21,477 - $31,476	657 Added 1.48%	45,111 $1.75 Million
Q4 2018 Jan 18, 2019	BUY	$37.1 - $50.11 $79,208 - $106,984	2,135 Added 5.05%	44,454 $1.87 Million
Q3 2018 Oct 30, 2018	BUY	$36.35 - $55.2 $184,839 - $280,692	5,085 Added 13.66%	42,319 $2.12 Million
Q2 2018 Jul 13, 2018	BUY	$33.85 - $50.65 $40,620 - $60,780	1,200 Added 3.33%	37,234 $1.42 Million
Q1 2018 Apr 30, 2018	SELL	$32.45 - $54.7 $347,215 - $585,290	-10,700 Reduced 22.9%	36,034 $1.45 Million
Q4 2017 Jan 30, 2018	SELL	$21.8 - $39.35 $1,962 - $3,541	-90 Reduced 0.19%	46,734 $1.64 Million
Q3 2017 Oct 20, 2017	BUY	$16.4 - $25.05 $328,000 - $501,000	20,000 Added 74.56%	46,824 $1.02 Million
Q2 2017 Aug 08, 2017	BUY	N/A	26,824	26,824 $499,000

Others Institutions Holding WVE

# of Institutions

164

Shares Held

117M

Call Options Held

148K

Put Options Held

109K

View Full List

About Wave Life Sciences Ltd.

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $1.24B
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

More about WVE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Matisse Capital, based on Form 13F filings with the SEC.

News

Stay updated on Matisse Capital with notifications on news.

Account